Call for Abstract

5th International Conference on Clinical Pharmacy and Public Health, will be organized around the theme “Healthy World by Pharmacist; Patient Welfare by Quality Pharmaceuticals”

Clinical Pharmacy 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Clinical Pharmacy 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Clinical Pharmacy is the field of pharmacy practice in which Pharmacists  provides better patient care that improves medication therapy and will improve health and disease prevention. The overall goal line of clinical pharmacy is to uphold the correct and appropriate use of prescription and non-prescription medicinal products and devices, and to minimize side effects and adverse effects. Clinical Pharmacists depend on their professional relationships with patients to tailor their advice to best meet individual patient needs and desires.

  • Track 1-1Pharmacoepidemiology
  • Track 1-2Public health and Communication Studies
  • Track 1-3Therapeutic drug monitoring
  • Track 1-4Preparation of personalized formulation
  • Track 1-5Clinical genomics and proteomics
  • Track 1-6Role of pharmacist in communicating and counseling patients

Public health refers to the science and art of preventing disease, prolonging life and promoting human health through organized efforts and informed choices of society, organizations, public and private communities and individuals. The dimensions of healthcare can surround a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity, as defined by the United Nations' WHO. Public health includes the interdisciplinary approaches of epidemiology, biostatistics and health services. Environmental health, health economics, public policy, mental health, community health, behavioral health are other important subfields. 

  • Track 2-1Public Health and Epidemiology
  • Track 2-2Community health
  • Track 2-3Health policy and management
  • Track 2-4Health Informatics and Big Data
  • Track 2-5Public Health Informatics
  • Track 2-6Health promotion and communication

Clinical pharmacology deals with study of drugs and their clinical use. It is supported by the basic science of pharmacology, with added focus on the application of pharmacological principles and quantitative methods. It has a wide scope, from the discovery of new target molecules to the effects of drug usage in whole populations. Clinical Toxicology is processes with are involved with the different forms of toxic chemicals and they associated with the different forms of diseases. It typically coincides with other sciences like as biochemistry, pharmacology and pathology. 

  • Track 3-1Drug Metabolism
  • Track 3-2Pharmacodynamics
  • Track 3-3Pharmacokinetics
  • Track 3-4Clinical Psychopharmacology
  • Track 3-5Clinical Immunopharmacology
  • Track 3-6Molecular Pharmacology
  • Track 3-7Neuropharmacology
  • Track 3-8Drug Overdose and Poisoning

Clinical research is a part of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. Clinical research is different from clinical practice. In clinical practice established treatments are used, while in clinical research evidence is collected to establish a treatment. Clinical research refers to the entire catalogue of a drug/device/biologic, in fact any test article from its inception in the lab to its introduction to the consumer market and beyond. Once the promising candidate or the molecule is identified in the lab, it is subjected to pre-clinical studies or animal studies where different aspects of the test article are studied.

  • Track 4-1Phases of clinical trials
  • Track 4-2Innovations in patient and community engagement in clinical trials
  • Track 4-3Data monitoring for trials with an adaptive design
  • Track 4-4Treating different ailments by clinical trials
  • Track 4-5Pre-clinical research leading to clinical trials

The duties of the Hospital Pharmacists is to be part of the medication management in hospitals, which encompasses the process in which medicines are selected, procured, delivered, prescribed, administered and reviewed to optimize the contribution that medicines make in generating informed and desired outcomes to enhance the safety and quality of all medicine related processes affecting patients in the hospital to ensure the 7 “rights” are respected: right patient, right dose, right route, right time, right drug with the right information and documentation.

  • Track 5-1Inventory medicine management
  • Track 5-2Medicines supply and automation
  • Track 5-3Controlled drugs in hospital pharmacy
  • Track 5-4Medicines information
  • Track 5-5Strategic medicines management
  • Track 5-6Mental health pharmacy

Drug Information provides topics relating to drug development and regulation that is of current relevance and importance, and will include the lists of proposed and recommended. The objective is to bring issues that are of primary concern to drug regulators and pharmaceutical manufacturers to the attention of a wide audience of health professionals and policy-makers concerned with the rational use of drugs. In effect, Conference seeks to relate regulatory activity to therapeutic practice. The dosage and administration includes the following categories of information for each of a drug’s indications to the extent the information is known and relevant to the safe and effective dosing and administration of the drug. For most drugs, not all categories of information described below will be available or relevant.

  • Track 6-1Patient Self Care
  • Track 6-2 Medication management service
  • Track 6-3Drug Information Centers & Skills
  • Track 6-4Formulary Services
  • Track 6-5Drug Interaction Facts
  • Track 6-6FDA Database

Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost and effects of a pharmaceutical product. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner. Pharmacoeconomics centres on the economic evaluation of pharmaceuticals, and can use cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis or cost-utility analysis. Quality-adjusted life years have become the dominant outcome of interest in pharmacoeconomic evaluations, and many studies employ a cost-per-QALY analysis.

  • Track 7-1Health Economics and Outcome research
  • Track 7-2Health Policy
  • Track 7-3Clinical pharmacy service evaluation
  • Track 7-4Cost Utility Analysis
  • Track 7-5Pharmacoeconomic Evaluation

A community pharmacy is a healthcare facility that emphasizes providing pharmaceutical services to a specific community. Typically, a registered pharmacist dispenses medicine from the community pharmacy. Community-based pharmacists responsibilities include: checking and dispensing of prescription drugs, providing advice on drug selection and usage to doctors and other health professionals and counseling patients in health promotion, disease prevention and the proper use of medicines. In most countries regulations govern how dispensaries may operate, with specific requirements for storage conditions, equipment and record keeping.

  • Track 8-1 Clinical Drug Development
  • Track 8-2Patient Counseling
  • Track 8-3Health Promotion
  • Track 8-4Compounding Pharmacists
  • Track 8-5Dispensing Pharmacists
  • Track 8-6Primary Care Pharmacists

Pharmacy informatics is the scientific field that focuses on medication-related data and knowledge within the continuum of healthcare systems - including its acquisition, storage, analysis, use and dissemination - in the delivery of optimal medication-related patient care and health outcomes.  It is the application of computers to the storage, retrieval and analysis of drug and prescription information. Pharmacy informatics can be thought of as a sub-domain of the larger professional discipline of healthcare informatics. Health informatics is the study of interactions between people, their work processes and engineered systems within health care with a focus on pharmaceutical care and improved patient safety.  Pharmacy informaticists work with pharmacy information management systems that help the pharmacist safe decisions about patient drug therapies with respect to, medical insurance records, drug interactions, as well as prescription and patient information.

  • Track 9-1Pharmacy IT
  • Track 9-2Healthcare Informatics
  • Track 9-3Clinical Informatics
  • Track 9-4Nursing Informatics
  • Track 9-5Biomedical Informatics
  • Track 9-6Public Health Informatics

Industrial Pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities. This broad research area relates to different functions in pharmaceutical industry and having contact areas with engineering and economics.

  • Track 10-1Drug discovery and development
  • Track 10-2Industrial pharmaceutics
  • Track 10-3Pharmacovigilance and clinical trials
  • Track 10-4Waste management
  • Track 10-5Product management
  • Track 10-6Good manufacturing practices

Pharmaceutical care is the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life. These outcomes are cure of a disease; elimination or reduction of a patient's symptomatology; arresting or slowing of a disease process; or preventing a disease or symptomatology. Pharmaceutical care involves the process through which a pharmacist cooperates with a patient and other professionals in designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient. Pharmaceutical care is a necessary element of health care and should be integrated with other elements.  It is provided for the direct benefit of the patient and the pharmacist is responsible directly to the patient for the quality of that care.

  • Track 11-1Pharmaceutical Care Models
  • Track 11-2Pharmaceutical Care Practice
  • Track 11-3Medication review
  • Track 11-4Quality of life assessment

Drug safety or it is also known as Pharmacovigilence is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. Pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

  • Track 12-1Drug Safety Reporting & Monitoring
  • Track 12-2Development Safety Update Reports
  • Track 12-3Clinical Safety Data Management
  • Track 12-4Drug Safety Services & Softwares

Drug Utilizations deals with study of Prescription, dispensing, ingesting, marketing, distribution, and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences.  It is interrelated to Epidemiology, Pharmacoepidemiology, Pharmacosurveillance and pharmacovigilance. Drug utilization research is thus an essential part of pharmacoepidemiology as it describes the extent, nature and determinants of drug exposure. Over time, the distinction between these two terms has become less sharp, and they are sometimes used interchangeably.

  • Track 13-1Drug Utilization Review
  • Track 13-2Formulary substitutions
  • Track 13-3Clinical abuse/misuse
  • Track 13-4Inappropriate duration of drug treatment

Disease management programs (DMPs) are structured treatment plans that aim to help people better manage their chronic disease and to maintain and improve quality of life. People with chronic conditions generally use more health care services, including physician visits, hospital care, and prescription drugs. Increases in the number of people living longer with chronic conditions coupled with rising health care expenditures have spurred health plans, employers, and the government to look for ways to reduce health care use and costs. Disease management programs are designed to improve the health of persons with specific chronic conditions and to reduce health care service use and costs associated with avoidable complications.

  • Track 14-1Evidence-Based Practice Guidelines
  • Track 14-2Collaborative Practice Models
  • Track 14-3Patient Self-Management Education
  • Track 14-4Process and Outcomes Measurement

Pharmacogenomics is the study of the role of the genome in drug response. It deals with the study of the technology that analyzes how the genetic makeup of an individual affects response to drugs and influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics (drug absorption, distribution, metabolism, and elimination) as well as drug receptor target effects. Pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

  • Track 15-1Pharmacogenetics
  • Track 15-2Mutagenicity and carcinogenicity
  • Track 15-3Chemotherapeutic agents
  • Track 15-4 Clinical genomics and proteomics